The effect of low concentrations of cyclic GMP (guanosine 3':5'-cyclic monophosphate) on the in^ vitro enzymatic activities of DNA-dependent RNA polymerases isolated from human peripheral blood lymphocytes has been investigated. In agreement with earlier studies which employed isolated nuclei as the enzyme source, an increase in the activity of partially purified RNA polymerase I is observed in the presence of cyclic GMP (10~8 to 10~l°M). RNA polymerase II activity is inhibited by the presence of cyclic GMP at concentrations between 10~4 and 10~l°M. RNA polymerase III activity is stimulated in a bimodal fashion by the presence of cyclic GMP with maximal activity noted at lO" 8 to 10" 10 M and 10" 5 M. In addition, [ 3 H]cyclic GMP binds specifically to chromatographic fractions which are known to contain RNA polymerases I, II and III. This binding to RNA polymerases II and III is apparently less tenacious as demonstrated by dissociation studies. The observations provide additional evidence for a role for cyclic GMP in the regulation of RNA synthesis.
INTRODUCTION
Evidence for the regulation of DNA-dependent RNA polymerases has been obtained from investigation of several diverse cellular systems. These include cells which have been stimulated by mitogens to proliferate (1), cells derived from embryonic tissues (2) , and hormone-dependent tissues (3, 4) . We have proposed (1, 5) that cyclic GMP functions as a small effector molecule in the regulation of DNA-dependent RNA polymerases I and II in nuclei isolated from non-proliferating human lymphocytes. The influence of cyclic GMP in this system was of interest because it established a functional role iii vitro for a small molecule in a complex experimental system. However, the variables involved in the analysis of whole nuclei precluded a determination of the precise mode of action with respect to the polymerases per se. Partially purified enzyme preparations were used to test the effect of cyclic GMP on polymerase activity in a less complex system. In the experiments reported in this communication, we demonstrate binding of cyclic GMP to those chromatographic fractions which support RNA synthesis. A modification of the protein structure and enzymatic activity is proposed as a result of cyclic GMP binding.
MATERIALS AMD METH0D6
A) Enzyme solubilization.
The enzymes were solubilized according to the methods of Foeder and Rutter (6) . Briefly, normal human peripheral blood lymphocytes were isolated using the Ficoll-Hypaque method (7) and frozen (-80°). The cells were homogenized in an Omnimixer (60 sees) at 1*° in TGMED buffer (0.01 M Trls-HCl, pH 7-9, 30* glycerol, 5 mM MgCl 2 , 0.1 mM EDTA, and 0.5 nM dithiothreitol). The resultant homogenate was filtered through two layers of cheesecloth, made 0.3 M in ammonium sulfate, and sonicated with 10 sec bursts with a Bronson sonicator. The homogenate was centrifuged at 30,000
x g for SO mins. The pellet was discarded, and ammonium sulfate was added to the supernatant (0.1*2 g/ml). The mixture was stirred for 60 mins at 105,000 x g and resuspended in TGMED buffer.
Protamine sulfate was added RHA polymerase assays were performed as described earlier (8) . In a final volume of 0.125 ml, the following components were present: 0.05 ml enzyme fraction, 0.025 ml calf thymus DNA (0.02 mg), and 0.05 ml Tris-HCl (56 mM, pH 7.9), 2 mM MnCl 2 , 0.6 mM each ATP.CTP.GTP, and 0.1 mM unlabelled UTP, and 2 uCi [ During the initial preparative phase, after the protamine sulfate Q precipitation step, the supernatant fraction was made 10~°M with radiolabelled cyclic GMP, and the preparation was stirred 60 mins at U°. Then, ammonium sulfate (O.I42 g/ml) was added and after stirring for 60 mins at h°, the precipitate was collected by centrifugation, as described previously.
The precipitate was suspended in TGMED buffer and dialyzed 2k hours at k°a gainst TGMED containing 10~°M non-radiolabelled cyclic GMP. Chromatography was performed, as described previously, except the column was pre-equilibrated with 10~"M cyclic GMP, and the gradient contained equimolar cyclic GMP. Aliquots of the column fractions were placed in Aquasol (New England Nuclear), and the radioactive cyclic GMP was determined by liquid scintillation counting. Protein elution profiles were monitored on «n column prt>-files and did not correspond to peaks of RNA polymerase activity.
RESULTS
Multiple species of DNA-dependent RNA polymerases can be partially purified using DEAE-Sephadex A-25 column chromatography, as shown in Figure 1 .
Normal peripheral blood lymphocytes contain at least three species which are defined by their elution characteristics and sensitivity to the fungal toxin a-amanitin (2). RNA polymerase I elutes at 0.12 M salt and is insensitive to a-amanitin (shown in the inset, Figure 1) ; RNA polymerase II elutes at 0.22Mŝ alt and is extremely sensitive to a-amanitin (10" 8 M); and a small peak of putative RNA polymerase III activity elutes at 0.3CM salt which is insensitive to a-amanitin. Whan cyclic GMP (10~9M) is added to the assay mixture, there is a demonstrable increase in the activities of RNA polymerases I and III and a decrease in the activity of RNA polymerase II.
As shown in Figure 2 , fractions which are affected by the addition of cyclic GMP to the synthetic mixture, are also able to bind An essential aspect of regulation is the ability of the regulatory molecule and an enzyme to associate and dissociate from each other. On the assumption that these interactions which are observed iri vitro might be related to regulatory mechanisms ill vivo, it was important to determine the reversibility of cyclic GMP binding to the polymerase proteins.
The interaction between cyclic GMP and the RNA polymerases was studied by analyzing short-term and long-term binding patterns. Short-term binding was determined by 15 minute incubations and indicated that cyclic GMP was bound to all three enzymes, as shown in Figure 2 . Long-term binding was studied by incubation of [ 3 H]cyclic GMP with the crude cellular homogenate, followed by extensive dialysis against non-radioactive cyclic GMP ( in large excess). (Figure 3 )The fractions were eluted from the column and small aliquots were counted to determine the localization of the label. Then, each fraction was analyzed for RNA synthetic ability.RKA polymerase I, II,and III activities were found to be similar to those reported in Figure 1 ; however, only one Nuclei isolated from non-proliferating cells were used to test this hypothesis .
In those experiments we demonstrated that mitogen-mediated, membrane-restricted events could be circumvented by the addition of cyclic GMP to human lymphocyte nuclei. The addition of a mitogen to intact cells or the addition of cyclic GMP to non-stimulated nuclei resulted in an increase in RNA polymerase I activity and a decrease in RNA polymerase II activity. In this communication, we have reported the binding of cyclic GMP to isolated and partially purified DNA-dependent RNA polymerases and the effect on relative activities of these enzymes.
It has been recently reported that DNA-dependent RNA polymerases from rat mammary gland contain little or no RNA polymerase I activity and a predominant species which elutes at 0.30M salt which is stimulated by cyclic GMP (5 x 10~5M) (10) . This is consistent with our observations using high concentrations of cyclic GMP; however, they did not study the effects of low concentrations in their test system. Cooriinant increases in cyclic GMP and ribosomal RNA synthesis have been observed in proliferating uterus through estrogen-dependent stimulation (11);
and there are reports of copurification of estradiol-receptor proteins and RNA polymerase I in immature oviduct and uterus (12, 13) .
In the studies presented in this communication, we interpret the effect of cyclic GMP on RNA synthesis to be a modification of the RNA polymerases per se. Studies are in progress to examine further the interaction of cyclic GMP, divalent cations, and the polymerases with template in order to understand more precisely the role which cyclic GMP plays in regulating eukaryotic RNA synthesis.
